Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Histrelin (Supprelin LA / Vantas) Peptide
GnRH agonist implant for central precocious puberty and prostate cancer.
What is Histrelin (Supprelin LA / Vantas)?
Histrelin (Supprelin LA / Vantas) is a gnrh agonist · endocrine peptide studied for central precocious puberty (supprelin la) and advanced prostate cancer (vantas). Below is an educational overview of Histrelin (Supprelin LA / Vantas) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Supprelin LA, Vantas
Central precocious puberty (Supprelin LA) and advanced prostate cancer (Vantas).
A small under-the-skin implant replaced once a year that quietly lowers sex hormones the whole time.
- •Implant-site reactions (redness, soreness, bruising)
- •Hot flashes
- •Fatigue
- •Headache
- •Implant breakage at removal
- •Cardiovascular and metabolic effects with long-term use
- •Bone density loss
- •Pregnancy
- •Known hypersensitivity to GnRH analogs
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Histrelin (Supprelin LA / Vantas) Mechanism of Action
Synthetic nonapeptide GnRH agonist delivered via a subcutaneous hydrogel implant providing continuous release for 12 months, desensitizing the pituitary and suppressing sex steroids.
Histrelin (Supprelin LA / Vantas) Research Areas & Benefits
Histrelin (Supprelin LA / Vantas) Dosage & Common Research Protocols
50 mg SC implant in inner upper arm; replaced every 12 months.
Protocols summarized for educational reference from published research. Not dosing guidance.
Histrelin (Supprelin LA / Vantas) Studies & Cited Research
Histrelin implant in CPP
Sustained suppression of pubertal progression with single annual implant.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Histrelin (Supprelin LA / Vantas) Side Effects & Safety Considerations
- •FDA-approved.
- •Implant site reactions and rare implant breakage at removal.
Common questions about Histrelin (Supprelin LA / Vantas)
More Hormonal peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.